B7-33
Single-chain relaxin B-chain analog targeting the RXFP1 receptor. Studied for anti-fibrotic effects in cardiac, renal, and pulmonary fibrosis models without
Buy more, save more
Total Price
$110
For research & laboratory use only. Not for human consumption.
Half-Life
Unknown
Administration Route
Subcutaneous injection
Anti-Fibrotic Peptide
Relaxin/RXFP1 agonist reduces organ fibrosis
Cardiac & Pulmonary
Studied for heart failure, pulmonary fibrosis, and kidney disease
Anti-Inflammatory
Reduces TGF-β driven fibroblast activation in chronic disease
Effect Profile
Cellular Longevity
Collagen Synthesis
Oxidative Protection
Energy Restoration
Mechanism of Action
Scientific Research
Nature Chemistry (2016)
Product FAQs
Related Products
BPC-157
Body Protection Compound 157 accelerates healing of tendons, ligaments, muscle, and gut tissue through angiogenesis and growth factor upregulation.
GHK-Cu
Naturally occurring copper-binding tripeptide (Gly-His-Lys-Cu2+) present in human plasma. Plasma levels decline 60% between ages 20-60. Studied for collagen